ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,351, issued on Feb. 24, was assigned to Duke University (Durham, N.C.).
"Compositions and methods for enhancing cancer immune checkpoint therapy" was invented by Chuan-Yuan Li (Durham, N.C.), Mengjie Hu (Durham, N.C.), Min Zhou (Durham, N.C.) and Fang Li (Durham, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides, in part, compositions and methods for enhancing the efficacy of immune checkpoint blockade therapy in a subject. Methods for identifying subjects that are appropriate for immune checkpoint blockade therapy are also provided."
The patent was filed on March 20, 2020, under Application No. 17/439,903.
*For f...